Session » Pediatric Rheumatology – Clinical Poster III
- 10:30AM-12:30PM
-
Abstract Number: 2183
Accuracy of AI Tools for Diagnosis of Connective Tissue Disease
- 10:30AM-12:30PM
-
Abstract Number: 2176
Applying Similarity Network Fusion to Identify Patient Clusters for People with Systemic Inflammatory Disease
- 10:30AM-12:30PM
-
Abstract Number: 2194
Association of Reticular Dermis and Subcutis Inflammatory Infiltrate with Musculoskeletal Involvement in Pediatric Localized Scleroderma
- 10:30AM-12:30PM
-
Abstract Number: 2177
CD59 Complement Membrane Regulator Deficiency: 12 Years of Clinical and Molecular Follow-up of 29 Patients
- 10:30AM-12:30PM
-
Abstract Number: 2174
Current Treatment of Macrophage Activation Syndrome Worldwide: The METAPHOR Project, a PReS/PRINTO Real-life International Survey
- 10:30AM-12:30PM
-
Abstract Number: 2178
Evaluating the Non-Inferiority of Mycophenolate Mofetil Compared to Methotrexate in Treating Juvenile Localized Scleroderma
- 10:30AM-12:30PM
-
Abstract Number: 2179
Evaluation of Diagnostic Concordance Between Telehealth Encounters and In-Person Follow-up Assessments in Pediatric Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 2202
Evolving Phenotypic and Genotypic Spectrum of Human ISG15 and USP18 Deficiencies
- 10:30AM-12:30PM
-
Abstract Number: 2204
Guidance for Stem Cell Therapy for Juvenile Systemic Sclerosis Patients
- 10:30AM-12:30PM
-
Abstract Number: 2173
Hope and Health in Adolescents with Chronic Musculoskeletal Pain
- 10:30AM-12:30PM
-
Abstract Number: 2196
Identifying Specific Criteria for Juvenile Systemic Sclerosis: A Comparison of Adult and Pediatric Ratings
- 10:30AM-12:30PM
-
Abstract Number: 2201
Immunodeficiency-Related Monogenic Autoinflammatory Diseases; Expanding Spectrum of Immunodysregulation Disorders
- 10:30AM-12:30PM
-
Abstract Number: 2207
Improvement Across Physician and Patient Reported Outcome Measures over a 24 Months-time Period in the Juvenile Systemic Scleroderma Inception Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2181
Large Pediatric Cohort with ANCA-associated Vasculitis at a Single Institution: Patient Characteristics, Clinical Course, and Outcomes
- 10:30AM-12:30PM
-
Abstract Number: 2184
Loss to Follow up After Transfer from Pediatric to Adult Care in Patients with JIA or jSLE
- 10:30AM-12:30PM
-
Abstract Number: 2189
Migratory Arthritis in Children: What Besides Rheumatic Fever?
- 10:30AM-12:30PM
-
Abstract Number: 2199
Mycobacterial Infection and Renal and Bladder Malignancy in 2 IFNopathy Patients on High Doses of JAK Inhibitors
- 10:30AM-12:30PM
-
Abstract Number: 2191
Optimizing Inpatient Kawasaki Disease Care
- 10:30AM-12:30PM
-
Abstract Number: 2197
Outcome Measures for the Assessment of Cutaneous and Musculoskeletal Manifestations of Juvenile Systemic Sclerosis: An International Collaborative Scoping Review and Survey of Current Practice
- 10:30AM-12:30PM
-
Abstract Number: 2187
Outcomes Following Tonsillectomy in Children with Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome
- 10:30AM-12:30PM
-
Abstract Number: 2188
Parent Verses Patient Perspectives of Health-Related Quality of Life Among Children with Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2182
PECOS (Pediatric SARS-CoV-2 MIS-C Long-term Outcomes Study): Preliminary Results
- 10:30AM-12:30PM
-
Abstract Number: 2175
Pediatric Rheumatology Clinic Referral Patterns at a Large Midwestern Center
- 10:30AM-12:30PM
-
Abstract Number: 2195
Pediatric Rheumatology Graduation: A One-Way Bridge to Adult Care?
- 10:30AM-12:30PM
-
Abstract Number: 2205
Presence of Nailfold Capillary Changes Correlates with More Severe Organ Involvement in Juvenile Systemic Scleroderma. Results of the Juvenile Scleroderma Inception Cohort
- 10:30AM-12:30PM
-
Abstract Number: 2193
Prospective Evaluation of Reactogenicity and Safety Following COVID-19 Vaccination in Children with a History of MIS-C
- 10:30AM-12:30PM
-
Abstract Number: 2198
Severe and Long-Term Outcomes of COVID-19 Infection and Vaccine Hesitancy and Adverse Events in Children with Pediatric Rheumatic Diseases: Insights from a COVID-19 Global Rheumatology Alliance Caregiver Survey
- 10:30AM-12:30PM
-
Abstract Number: 2180
The Association Between Age at Diagnosis and Patient-Reported Outcomes in Patients with Vasculitis
- 10:30AM-12:30PM
-
Abstract Number: 2203
The Association of Autoantibodies with Clinical Manifestations and Long-term Outcomes in Juvenile- and Adult-onset Systemic Sclerosis
- 10:30AM-12:30PM
-
Abstract Number: 2186
The Exploration of Secondary Amplified Musculoskeletal Pain Syndrome (AMPS) in Pediatric Patients with Rheumatologic Disease
- 10:30AM-12:30PM
-
Abstract Number: 2206
There Is No Difference in Major Organ Involvement Andantibody Pattern Between Diffuse and Limited Subtypejuvenile Onsetsystemic Scleroderma Patients
- 10:30AM-12:30PM
-
Abstract Number: 2185
TRACER: Transition to Adulthood Through Coaching and Empowerment in Rheumatology, a Feasibility Study
- 10:30AM-12:30PM
-
Abstract Number: 2190
Uncovering Inborn Errors of Immunity in Pediatric Rheumatology
- 10:30AM-12:30PM
-
Abstract Number: 2192
Utilizing Electronic Health Record Pre-Consultation Data to Create a Predictive Algorithm for Diagnosis of Chronic Pediatric Rheumatic Conditions
- 10:30AM-12:30PM
-
Abstract Number: 2200
Whole Blood Transcriptome Profiling in Juvenile Systemic Sclerosis Patients Reveals Active Immune Upregulation and Enhanced Fibrotic Signature